| 125 | 13 | 7 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:探讨替吉奥联合奥沙利铂化疗对老年胃癌患者血清肿瘤标志物,基质金属蛋白酶及免疫功能的影响。方法:将80例老年胃癌患者随机分为对照组和观察组(每组40例),对照组给予卡培他滨片联合奥沙利铂方案,观察组患者给予替吉奥联合奥沙利铂方案,两组均治疗6个周期,比较治疗前后两组血清肿瘤标志物、基质金属蛋白酶及免疫功能水平。结果:治疗前,两组CEA、CA125、CA19-9、MMP-2、MMP-9、CD3+、CD4+、CD8+、CD4+/CD8+水平比较,差异无统计学意义(P>0.05);治疗后,两组CEA、CA125、CA19-9、MMP-2、MMP-9、CD8+水平均显著低于组内治疗前,且观察组CEA、CA125、CA19-9、MMP-2、MMP-9、CD8+水平显著低于对照组,差异有统计学意义(P<0.05);与组内治疗前相比,两组治疗后CD3+、CD4+、CD4+/CD8+水平均显著升高,观察组治疗后水平均显著高于对照组,差异有统计学意义(P<0.05)。结论:替吉奥与奥沙利铂联合化疗可有效降低老年胃癌患者血清肿瘤标志物及基质金属蛋白酶水平,改善免疫功能,具有重要临床价值。
Abstract：Objective:To investigate the effect of Compound Tegafur and Oteracil Potassium Sustained Capsules(S-1)combined with oxaliplatin chemotherapy on serum tumor marker matrix metalloproteinase and immune function in elderly patients with gastric cancer.Methods:According to the random data table,80 cases of elderly patients with gastric cancer were divided into control group and observation group(n=40),patients in the control group were treated with oxaliplatin combined with Capecitabine Tablets,and the observation group patients were treated with S-1 combined with oxaliplatin,all treated for 6 cycles,before and after treatment,levels of serum tumor markers,matrix metalloproteinase and immune function were compared between the two groups.Results:Before treatment,there was no significant difference in the levels of CEA,CA125,CA19-9,MMP-2,MMP-9,CD3+,CD4+,CD8~+and CD4+/CD8~+between the two groups(P>0.05);After treatment,the levels of CEA,CA125,CA19-9,MMP-2,MMP-9 and CD8~+in the two groups were significantly lower than those in the same group before treatment,and the levels of the observation group[(7.79±2.78)ng/ml,(22.56±7.31)U/mL,(13.48±3.05)U/mL,(57.84±8.93)ng/mL,(199.14±67.39)ng/mL and(26.21±4.18)%]were significantly lower than those in the control group(P<0.05);Compared with the group before treatment,the levels of CD3+,CD4~+and CD4+/CD8~+in the two groups were significantly increased,and the observation group[(66.89±5.84)%,(41.63±5.24)%and(1.37±0.29)]was significantly higher than the control group(all P<0.05).Conclusion:S-1 combined with oxaliplatin chemotherapy can effectively reduce serum tumor markers and matrix metalloproteinase levels,improve immune function,has an important clinical value.
1郭军,刘登湘,王娜,等.健脾滋肾为本的中医辨证论治联合XE-LOX方案化疗对老年晚期胃癌疗效及生存期的影响观察[J].北京中医药,2015,34(4):317-320.
2刘阳,刘婕,刘文.胃癌根治切除术联合5-氟尿嘧啶治疗老年胃癌病人的临床疗效及对免疫功能的影响[J].实用老年医学,2017,31(1):42-45.
3韩芬叶.替吉奥联合奥沙利铂用于胃癌根治术后辅助化疗的安全性分析及护理[J].实用临床医药杂志,2014(18):33-35.
4 Ema A,Yamashita K,Sakuramoto S,et al.Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1chemotherapy[J].Gastric Cancer,2014,17(1):67-75.
5 Imamura H,Kishimoto T,Takiuchi H,et al.Phase II study of S-1monotherapy in patients over 75years of age with advanced gastric cancer(OGSG0404)[J].Journal of Chemotherapy,2014,26(1):57-61.
6胡泽成,赵晓春,伍小平,等.紫杉醇脂质体联合替吉奥与XE-LOX在胃癌术后辅助化疗中的对比研究[J].中国全科医学,2015,18(13):1545-1548.
7沈东杰,刘涛,赵恩昊,等.替吉奥联合奥沙利铂治疗进展期胃癌的疗效及对癌组织中MMP-9和VEGF表达的影响[J].实用临床医药杂志,2015,19(5):41-43,47.
8中华人民共和国卫生部医政司.胃癌诊疗规范(2011年版)[J].中国医学前沿杂志:电子版,2012,4(5):62-71.
9左婷婷,郑荣寿,曾红梅,等.中国胃癌流行病学现状[J].中国肿瘤临床,2017,44(1):52-58.
10 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].Ca A Cancer Journal for Clinicians,2016,66(2):115-132.
11姚凡保,黄仕尧,付汐,等.胃癌患者血清中OPN、sLAG-3、DKK-1含量检测及其与肿瘤病理分期、凋亡基因表达的关系[J].海南医学院学报,2016,22(6):596-599.
12 Trang TT,Nagashima H,Uchida T,et al.RAD51G135Cgenetic polymorphism and their potential role in gastric cancer induced by Helicobacter pylori infection in Bhutan[J].Epidemiol Infect,2016,144(2):234-240.
13 Park SH,Sohn TS,Lee J,et al.Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer:final report of the adjuvant chemoradiotherapy in stomach tumors trial,including survival and subset analyses[J].Journal of Clinical Oncology,2015,33(28):3130-3136.
14 Zhao W,Dong S,Duan B,et al.HOTAIR is a predictive and prognostic biomarker for patients with advanced gastric adenocarcinoma receiving fluorouracil and platinum combination chemotherapy[J].American journal of translational research,2015,7(7):1295-1302.
15 Xu Z,Chen Y,Gu D,et al.SOD2rs4880CT/CC genotype predicts poor survival for Chinese gastric cancer patients received platinum and fluorouracil based adjuvant chemotherapy[J].American journal of translational research,2015,7(2):401-410.
16 Shen L,Li J,Xu J,et al.Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer:randomized,double-blind,phase III study(AVATAR study)[J].Gastric cancer,2015,18(1):168-176.
17 Ryu MH,Yoo C,Kim JG,et al.Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer[J].European Journal of Cancer,2015,51(4):482-488.
18崔敬敬,高吉俊,张黎娟.卡培他滨与奥沙利铂联合治疗晚期胃癌的疗效观察及护理[J].中国医院用药评价与分析,2016,16(5):585-587.
19 Shitara K,Chin K,Yoshikawa T,et al.Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2gastrectomy[J].Gastric Cancer,2017,20(1):175-181.
20 Wang W,Chen XL,Zhao SY,et al.Prognostic significance of preoperative serum CA125,CA19-9and CEA in gastric carcinoma[J].Oncotarget,2016,7(23):35423-35436.
21 Yin LK,Sun XQ,Mou DZ.Value of combined detection of serum CEA,CA72-4,CA19-9and TSGF in the diagnosis of gastric cancer[J].Asian Pac J Cancer Prev,2015,16(9):3867-3870.
22 Adabi Z,Mohsen Ziaei SA,Imani M,et al.Genetic Polymorphism of MMP2Gene and Susceptibility to Prostate Cancer[J].Arch Med Res,2015,46(7):546-550.
23 Gunawardena I,Arendse M,Jameson MB,et al.Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population:matrix metalloproteinase-2and sialyl Lewis x antigen[J].ANZ J Surg,2015,85(11):843-848.
24 Kindlund B,Sj9ling,Yakkala C,et al.CD4+regulatory Tcells in gastric cancer mucosa are proliferating and express high levels of IL-10but little TGF-β[J].Gastric Cancer,2017,20(1):116-125.
25 Takano S,Saito H,Ikeguchi M.An increased number of PD-1+and Tim-3+CD8+T cells is involved in immune evasion in gastric cancer[J].Surgery today,2016,46(11):1341-1347.
26黄旭宏,宋玉国,刘春雷,等.胃癌与T淋巴细胞亚群关系的研究进展[J].世界华人消化杂志,2016,24(15):2331-2335.
27邓峰,张茹虎,朱磊.奥沙利铂联合卡培他滨对中晚期胃癌患者术后化疗的疗效及对血清CA125、CEA、TPS、CYFRA21-1、CA19-9及T淋巴细胞亚群水平的影响[J].海南医学院学报,2016,22(17):2011-2014.
基本信息:
DOI：10.13210/j.cnki.jhmu.20170926.015
中图分类号:R735.2
引用信息:
[1]单永锋,陈艳.替吉奥联合奥沙利铂方案治疗老年胃癌对患者血清肿瘤标志物、基质金属蛋白酶及免疫功能的影响[J].海南医学院学报,2017,23(19):2720-2723.DOI:10.13210/j.cnki.jhmu.20170926.015.
基金信息:
江苏省卫生厅重点学科省内开放课题(KF201512)~~
2017-09-26
2017-09-26
2017-09-26